Luger NM - Search Results

1

The involvement of prostaglandins in tumorigenesis, tumor-induced osteolysis and bone cancer pain.

Sabino MC, Ghilardi JR, Feia KJ, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, De Filipe C, Mantyh PW. Sabino MC, et al. Among authors: luger nm. J Musculoskelet Neuronal Interact. 2002 Dec;2(6):561-2. J Musculoskelet Neuronal Interact. 2002. PMID: 15758394 Free article. No abstract available.

2

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain.

Luger NM, Sabino MAC, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW. Luger NM, et al. Pain. 2002 Oct;99(3):397-406. doi: 10.1016/S0304-3959(02)00102-1. Pain. 2002. PMID: 12406514

3

Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Sabino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW. Sabino MA, et al. Among authors: luger nm. Cancer Res. 2002 Dec 15;62(24):7343-9. Cancer Res. 2002. PMID: 12499278

4

Different tumors in bone each give rise to a distinct pattern of skeletal destruction, bone cancer-related pain behaviors and neurochemical changes in the central nervous system.

Sabino MA, Luger NM, Mach DB, Rogers SD, Schwei MJ, Mantyh PW. Sabino MA, et al. Among authors: luger nm. Int J Cancer. 2003 May 1;104(5):550-8. doi: 10.1002/ijc.10999. Int J Cancer. 2003. PMID: 12594809

5

Bone cancer pain: the effects of the bisphosphonate alendronate on pain, skeletal remodeling, tumor growth and tumor necrosis.

Sevcik MA, Luger NM, Mach DB, Sabino MA, Peters CM, Ghilardi JR, Schwei MJ, Röhrich H, De Felipe C, Kuskowski MA, Mantyh PW. Sevcik MA, et al. Among authors: luger nm. Pain. 2004 Sep;111(1-2):169-80. doi: 10.1016/j.pain.2004.06.015. Pain. 2004. PMID: 15327821

6

Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.

Peters CM, Ghilardi JR, Keyser CP, Kubota K, Lindsay TH, Luger NM, Mach DB, Schwei MJ, Sevcik MA, Mantyh PW. Peters CM, et al. Among authors: luger nm. Exp Neurol. 2005 May;193(1):85-100. doi: 10.1016/j.expneurol.2004.11.028. Exp Neurol. 2005. PMID: 15817267

7

Bone cancer pain: from model to mechanism to therapy.

Luger NM, Mach DB, Sevcik MA, Mantyh PW. Luger NM, et al. J Pain Symptom Manage. 2005 May;29(5 Suppl):S32-46. doi: 10.1016/j.jpainsymman.2005.01.008. J Pain Symptom Manage. 2005. PMID: 15907645 Free article. Review.

8

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.

Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW. Honore P, et al. Among authors: luger nm. Nat Med. 2000 May;6(5):521-8. doi: 10.1038/74999. Nat Med. 2000. PMID: 10802707

9

Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

Honore P, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, Clohisy DR, Mantyh PW. Honore P, et al. Among authors: luger nm. Neuroscience. 2000;98(3):585-98. doi: 10.1016/s0306-4522(00)00110-x. Neuroscience. 2000. PMID: 10869852

10

Osteoprotegerin diminishes advanced bone cancer pain.

Luger NM, Honore P, Sabino MA, Schwei MJ, Rogers SD, Mach DB, Clohisy DR, Mantyh PW. Luger NM, et al. Cancer Res. 2001 May 15;61(10):4038-47. Cancer Res. 2001. PMID: 11358823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters